Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 10,801–10,820 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

VIT C/GSH 1.25%-1.25% OPHTH, Ophthalmic, 1.25%, Rx only, 15 mL Plastic/ Multiple Dose bottle, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

ALPHA LIPOIC ACID 25ML MDV 25MG/ML INJ, Injection, 25mg/mL, Rx only, 25 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PGE1/PROCAINE 5ML MDV 40MCG/ML/0.1% INJ, Injection, 40mcg/mL, 0.1%, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PGE1/PROCAINE 5ML MDV 20MCG/ML/0.1% INJ, Injection, 20mcg/ml 0.1%, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

QUAD MIX 50/30/1/0.2 5ML MDV (CALIF) MCG/MG/MG/MG/ML INJ, Injection, 50mcg/30mg/1mg/0.2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

QUAD MIX 1/30/0.5/0.1 5ML MDV MCG/MG/MG/MG/ML INJ, Injection, 1mcg/30mg/0.5mg/0.15mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 6/18/0.6 5ML MDV MCG/MG/MG/ML INJ, Injection, 6mcg/18mg/0.6mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 5/30/0.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 5mcg/30mg/0.5mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 5.95/17.8572/0.6 5ML MDV MCG/MG/MG/ML INJ, Injection, 5.95mcg/17.85mg/0.6mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 5.88/17.65/0.588 5ML MDV MCG/MG/MG/ML INJ, , Injection, 5.88mcg/17.65mg/0.588mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 45.45/27.27/0.45 5ML MDV MCG/MG/MG/ML INJ, Injection, 45.45mcg/27.27mg/0.45mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 40/30/4 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/4mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 40/30/2 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 30/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 30mcg/30mg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 20/30/2 5ML MDV MCG/MG/MG/1ML INJ, Injection, 20mcg/30mg/2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial , Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 20/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/30mg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 20/30/0.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/30mg/0.5mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 20/20/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/20mg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 16.7/4/0.27 5ML MDV MCG/MG/MG/ML INJ, Injection, 16.7mcg/4mg/0.27mg/ml, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

TRI MIX 13/30/0.8 5ML MDV MCG/MG/MG/ML INJ, Injection, 13mcg/30mg/0.8mg/mL, RX only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.